- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07943338
Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital (SATISCHOL)
A Prospective Observational Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital
SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.
The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.
Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).
A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.
Studieoversikt
Status
Detaljert beskrivelse
Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.
Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.
Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.
Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.
This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.
Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.
Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.
Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.
Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.
The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Niki CHRISTOU, Professor
- Telefonnummer: 05 55 05 55 55
- E-post: niki.christou@chu-limoges.fr
Studer Kontakt Backup
- Navn: Oumar SECK
- E-post: cheikhououmar.seck@chu-limoges.fr
Studiesteder
-
-
-
Limoges, Frankrike, 87042
- Rekruttering
- Chu Limoges
-
Ta kontakt med:
- Niki CHRISTOU, Professor
- Telefonnummer: 05 55 05 55 55 0555058630
- E-post: niki.christou@chu-limoges.fr
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.
Beskrivelse
Inclusion Criteria:
- Age 18 years or older.
- Patients undergoing elective cholecystectomy.
- Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
- Patients able to complete questionnaires independently or with the assistance of a caregiver.
- Patients covered by a health insurance scheme.
- Patients who have not objected to participation in the study.
Exclusion Criteria:
- Patients undergoing emergency surgery.
- Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
- Patients with a history of chronic gastrointestinal disease.
- Patients with known gallbladder cancer.
- Patients scheduled for open laparotomy.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Patients undergoing elective cholecystectomy
Adult patients undergoing elective cholecystectomy at Limoges University Hospital |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of patients with a visual analogue scale (VAS) pain
Tidsramme: From two hours after surgery to four weeks postoperatively.
|
Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery. |
From two hours after surgery to four weeks postoperatively.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of patients with a VAS pain score
Tidsramme: Two hours after surgery.
|
Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy. |
Two hours after surgery.
|
|
Proportion of patients experiencing early postoperative complications
Tidsramme: Up to four weeks after surgery.
|
Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification. |
Up to four weeks after surgery.
|
|
Description of intraoperative pain management techniques
Tidsramme: During surgery
|
Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block . For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable. |
During surgery
|
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score
Tidsramme: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2) |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Change in the EQ-5D-5L visual analogue scale (VAS)
Tidsramme: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2). |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Description of patient-reported experience using the study-specific PREMS questionnaire
Tidsramme: Postoperative assessment at 3 to 6 weeks (T2)
|
Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item. |
Postoperative assessment at 3 to 6 weeks (T2)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Niki CHRISTOU, Professor, University Hospital, Limoges
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Smerte
- Nevrologiske manifestasjoner
- Sykdommer i nervesystemet
- Postoperative komplikasjoner
- Patologiske prosesser
- Sykdommer i fordøyelsessystemet
- Nevroatferdsmanifestasjoner
- Galleveissykdommer
- Galleblæren sykdommer
- Perseptuelle forstyrrelser
- Patologiske tilstander, tegn og symptomer
- Tegn og symptomer
- Smerter, postoperativt
- Kolecystitt
- Agnosia
- Kolelithiasis
Andre studie-ID-numre
- 87RI24_0064 (SATISCHOL)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .